Cyproheptadine hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula 2C21H21N.2ClH.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NJ82J0F8QC, chemically known as 5-(1-methylpiperidylidene-4)-5h-dibenzo(a,d)cyclopheptene but more generally known as cyproheptadine hydrochloride, which bears US NIH Compound Identifier 2913. European Medicines Agency schedules Cyproheptadine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01537MIG. Most nations, for tariff and trade purposes, schedule cyproheptadine hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, CYPROHEPTADINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Cyproheptadine hydrochloride bears US NLM identifiers UMLS ID C0354872 and NCI Concept Code C28949. SMILES: CN1CCC(=C2C3CCCCC3C=CC4C2CCCC4)CC1.CN1CCC(=C2C3CCCCC3C=CC4C2CCCC4)CC1.O.O.O.CL.CL.